The Intercontinental Journal of Internal Medicine aims to publish issues related to all fields of internal medicine of the highest scientific and clinical value at an international level and accepts articles on these topics. This journal is indexed by indices that are considered international scientific journal indices (DRJI, ESJI, OAJI, etc.). According to the current Associate Professorship criteria, it is within the scope of International Article 1-d. Each article published in this journal corresponds to 5 points.

EndNote Style
Case Report
Levetirasetam induced acute pancreatitis : an uncommon case report
Acute pancreatitis is an acute inflammatory event involving the pancreas and causes significant mortality and morbidity. The most common causes are gastrointestinal stones and alcohol abuse, but well-known drugs used in daily practice can also cause acute pancreatitis. In this rare case report, we aimed to present a case of levetiracetam-associated acute pancreatitis.

1. Zerem E, Kurtcehajic A, Kunosic S, Zerem Malkocevic D, ZeremO. Current trends in acute pancreatitis: Diagnostic and therapeuticchallenges. World J Gastroenterol. 2023;29(18):2747-2763. doi: 10.3748/wjg.v29.i18.2747.
2. Kiyak M, Tanoglu A. Comparison of the Efficacy of Balthazar Scoreand C-Reactive Protein-Albumin Ratio for Determination of AcutePancreatitis Severity. Curr Health Sci J. 2022;48(1):81-87. doi: 10.12865/CHSJ.48.01.12.
3. Tanoglu A, Yazgan Y, Kaplan M, et al. Trimetazidine significantlyreduces cerulein-induced pancreatic apoptosis. Clin Res HepatolGastroenterol. 2015;39(1):145-150. doi:10.1016/j.clinre.2014.06.003.
4. Kaplan M, Yazgan Y, Tanoglu A, et al. Effectiveness of interleukin-1receptor antagonist (Anakinra) on cerulein-induced experimentalacute pancreatitis in rats. Scand J Gastroenterol. 2014;49(9):1124-1130.doi: 10.3109/00365521.2014.926983.
5. Güney BÇ, Tanoğlu A, Yeniçeri M, Çırak Z, Sade AG, Taştan YÖ,Serindağ Z, Kaplan M. Favorable efficacy of adalimumab treatment inexperimental acute pancreatitis model. Turk J Med Sci. 2022 ;52(6):1821-1828. doi: 10.55730/1300-0144.5528.
6. Kaplan M, Tanoğlu A, Çakır Güney B, et al. Golimumab amelioratespancreatic inflammatory response in the cerulein-induced acutepancreatitis in Rats. Turk J Gastroenterol. 2022;33(11):918-924. doi:10.5152/tjg.2022.21456.
7. Tanoğlu EG, Tanoğlu A, Meriçöz Aydın MÇ, Esen MF. Melatonin hasfavorable preventive effects on experimental chronic pancreatitis ratmodel. Turk J Med Sci. 2021;51(5):2734-2740. doi: 10.3906/sag-2103-134.
8. Yildirim M, Kaplan M, Duzenli T, et al. Pentoxifylline has favorablepreventive effects on experimental chronic pancreatitis model. Scand JGastroenterol. 2020 ;55(2):236-241. doi: 10.1080/00365521.2020.1712471.
9. Hançerli Y, Kaplan M, Tanoğlu A, et al. Efficacy of tocilizumabtreatment in cerulein-induced experimental acute pancreatitismodel in rats. Turk J Gastroenterol. 201728(6):485-491. doi: 10.5152/tjg.2017.16738.
10. Lyseng-Williamson KA. Levetiracetam: a review of its use in epilepsy.Drugs. 2011;71(4):489-514. doi: 10.2165/11204490-000000000-00000.
11. Azar NJ, Aune P. Acute pancreatitis and elevated liver transaminasesafter rapid titration of oral levetiracetam. J Clin Neurosci. 2014;21(6):1053-1054. doi: 10.1016/j.jocn.2013.08.016.
12. Tanoglu A, Cagiltay E, Beyazit Y. Spiramycin-associated AcutePancreatitis: Cause or Coincidence? Med Sci. 2015;4(2):2352-2355.
13. Tanoğlu A, Çağıltay E. Tigecycline induced acute pancreatitis: Suspicionis the first step in diagnosis. Anatolian Curr Med. 2021;3(3):262-3.doi:10.38053/acmj.955678.
14. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating theprobability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239-45.
Volume 1, Issue 3, 2023
Page : 71-72